These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1722753)

  • 21. 5-Hydroxytryptophol and 5-hydroxyindoleacetic acid levels in rat brain: effects of various drugs affecting serotonergic transmitter mechanisms.
    Beck O; Lundman A; Jonsson G
    J Neural Transm; 1987; 69(3-4):287-98. PubMed ID: 2442302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased total activity in the rat after L-tryptophan plus the monoamine oxidase-A inhibitor amiflamine but not after L-tryptophan plus clorgyline.
    Archer T; Fowler CJ; Fredriksson A; Lewander T; Magnusson O; Mohringe B; Söderberg U
    Br J Pharmacol; 1985 Jul; 85(3):581-90. PubMed ID: 2411326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of D, L-alpha-ethyltryptamine acetate on serotonin metabolism.
    GREIG ME; GIBBONS AJ
    Arch Int Pharmacodyn Ther; 1962 Mar; 136():147-52. PubMed ID: 13901665
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3H]paroxetine binding to cerebral cortical membranes of the rat.
    Graham D; Tahraoui L; Langer SZ
    Neuropharmacology; 1987 Aug; 26(8):1087-92. PubMed ID: 2958720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
    Yeh SY
    Synapse; 1999 Mar; 31(3):169-77. PubMed ID: 10029234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones.
    Colado MI; Green AR
    Eur J Pharmacol; 1995 Jul; 280(3):343-6. PubMed ID: 8566105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs.
    Blier P; Bouchard C
    Br J Pharmacol; 1994 Oct; 113(2):485-95. PubMed ID: 7834200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
    Freezer A; Salem A; Irvine RJ
    Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
    Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
    J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural requirements for uptake into serotoninergic neurones.
    Ross SB; Ask AL
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):270-7. PubMed ID: 7368945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of brain 5-HT neurons by two alpha-methylated tryptamine derivatives.
    Arai Y; Tadano T; Yonezawa A; Fujita T; Kinemuchi H; Kisara K
    Prog Brain Res; 1995; 106():269-75. PubMed ID: 8584663
    [No Abstract]   [Full Text] [Related]  

  • 33. 5-Iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine.
    Nichols DE; Johnson MP; Oberlender R
    Pharmacol Biochem Behav; 1991 Jan; 38(1):135-9. PubMed ID: 1826785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of amiflamine and related compounds on the accumulation of biogenic monoamines in rat brain slices in vitro and ex vivo in relation to their behavioural effects.
    Rényi L; Ross SB
    Acta Pharmacol Toxicol (Copenh); 1985 May; 56(5):416-26. PubMed ID: 4036634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of serotonergic denervation on the density and plasticity of brain muscarinic receptors in the rat.
    Alonso R; Soubrie P
    Synapse; 1991 May; 8(1):30-7. PubMed ID: 1714634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Research on the mechanism of inhibition of respiratory activity of rat cerebral cortex slices induced by 5-hydroxytryptamine].
    Ivaldi G; Macrì I
    Rass Neurol Veg; 1965 Jun; 19(3):235-42. PubMed ID: 5895814
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of acute and extended monoamine oxidase inhibition upon 5-hydroxyindoles in maturing mouse brain.
    Baker PC; Hoff KM
    Gen Pharmacol; 1991; 22(2):347-52. PubMed ID: 1711492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonazepam-induced up-regulation of serotonin1 and serotonin2 binding sites in rat frontal cortex.
    Wagner HR; Reches A; Yablonskaya E; Fahn S
    Adv Neurol; 1986; 43():645-51. PubMed ID: 2418653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ; Robinson SE; Rosecrans JA
    Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.